Articles tagged as 'LatinAmerica'

8 results

Nicaragua in the network
The National Health Regulatory Authority in Nicaragua is working across all sectors to improve medicines safety in their country.

Using humour to fight fake medicines in Ecuador
Creative pharmacovigilance experts have turned to comedy to avert potential tragedy, as they take on the pervasive problem of counterfeit medicines in Ecuador.

COFEPRIS boosts ability to receive and analyse adverse drug reaction reports
The move to VigiFlow has proven to be a boon for pharmacovigilance in Mexico, improving report management practices in Latin America’s second biggest medicines market.

Pharmacovigilance in Brazil
Despite the difficulties in monitoring drug safety in a country with more than 200 million inhabitants, Brazil's pharmacovigilance system is undergoing profound change.

Regional experts gather in Lima for signal workshop
Regional cooperation and global coordination combined to boost signal detection capacity and expertise during a major initiative held in Peru earlier this year.

EsSalud, Peru – Collaboration, quality, and clinical perspectives
A clinical perspective from a multidisciplinary team is the first step for better individual case-level causality assessments and clinical decisions.

Paraguay deploys technology to promote ADR reporting
Smart solutions and an integrated approach across both public and private sectors are helping Paraguay build a dynamic reporting culture and practice.

National centres share experience at 42nd annual meeting
The 42nd Annual NC meeting drew the global pharmacovigilance community to Bogotá, Colombia for an intensive programme of learning, experience sharing and inspiration.

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more